John Atack

14.4k total citations · 1 hit paper
189 papers, 10.2k citations indexed

About

John Atack is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, John Atack has authored 189 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Cellular and Molecular Neuroscience, 106 papers in Molecular Biology and 30 papers in Cognitive Neuroscience. Recurrent topics in John Atack's work include Neuroscience and Neuropharmacology Research (104 papers), Memory and Neural Mechanisms (29 papers) and Receptor Mechanisms and Signaling (28 papers). John Atack is often cited by papers focused on Neuroscience and Neuropharmacology Research (104 papers), Memory and Neural Mechanisms (29 papers) and Receptor Mechanisms and Signaling (28 papers). John Atack collaborates with scholars based in United Kingdom, United States and Belgium. John Atack's co-authors include Gerard R. Dawson, Ruth M. McKernan, Cyrille Sur, Keith A. Wafford, Paul J. Whiting, Elaine K. Perry, Robert H. Perry, Neil Collinson, Andrew Fairbairn and Owain W. Howell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

John Atack

187 papers receiving 9.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA_AReceptor

2002 509 citations Neil Collinson, Cyrille Sur et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
John Atack	5.2k	4.2k	1.9k	1.5k	1.4k	189	10.2k
Alvin V. Terry	2.8k 0.5×	3.8k 0.9×	1.2k 0.7×	1.1k 0.7×	2.0k 1.4×	205	8.7k
S.J. Enna	6.8k 1.3×	4.7k 1.1×	986 0.5×	1.8k 1.2×	935 0.6×	170	10.1k
Frank S. Menniti	5.0k 1.0×	6.4k 1.5×	783 0.4×	807 0.5×	2.4k 1.7×	109	10.3k
Andrzej Pilc	6.1k 1.2×	3.1k 0.8×	1.1k 0.6×	915 0.6×	2.0k 1.4×	283	10.0k
Jean C. Shih	4.4k 0.9×	4.3k 1.0×	1.0k 0.6×	985 0.7×	1.0k 0.7×	191	11.5k
Jean‐Charles Schwartz	7.3k 1.4×	8.3k 2.0×	1.8k 1.0×	1.6k 1.1×	1.7k 1.2×	221	15.4k
Reginald L. Dean	3.3k 0.6×	3.0k 0.7×	2.3k 1.3×	1.4k 0.9×	2.9k 2.0×	69	8.3k
Richard B. Mailman	5.7k 1.1×	4.8k 1.2×	1.2k 0.7×	691 0.5×	741 0.5×	267	11.1k
Tiziana Mennini	3.8k 0.7×	3.0k 0.7×	518 0.3×	1.2k 0.8×	1.0k 0.7×	270	9.3k
Stefano L. Sensi	3.8k 0.7×	4.6k 1.1×	835 0.5×	2.9k 2.0×	1.7k 1.2×	215	12.4k

Countries citing papers authored by John Atack

Since Specialization

Citations

This map shows the geographic impact of John Atack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Atack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Atack more than expected).

Fields of papers citing papers by John Atack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Atack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Atack. The network helps show where John Atack may publish in the future.

Co-authorship network of co-authors of John Atack

This figure shows the co-authorship network connecting the top 25 collaborators of John Atack. A scholar is included among the top collaborators of John Atack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Atack. John Atack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atack, John, et al.. (2024). Basmisanil, an α5-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice. Neuroscience Letters. 833. 137828–137828. 2 indexed citations

Mitchell, Scott J., Delia Belelli, Stephen J. Martin, et al.. (2024). Neurosteroid Modulation of Synaptic and Extrasynaptic GABAA Receptors of the Mouse Nucleus Accumbens. Biomolecules. 14(4). 460–460. 3 indexed citations

Atack, John, et al.. (2022). Exploring Calbindin-IMPase fusion proteins structure and activity. Biochemistry and Biophysics Reports. 30. 101266–101266. 2 indexed citations

Elvers, Karen T, S. Mark Roe, Simon E. Ward, et al.. (2022). Tyrosine 121 moves revealing a ligandable pocket that couples catalysis to ATP-binding in serine racemase. Communications Biology. 5(1). 346–346. 5 indexed citations

Belelli, Delia, et al.. (2021). Relating neurosteroid modulation of inhibitory neurotransmission to behaviour. Journal of Neuroendocrinology. 34(2). e13045–e13045. 18 indexed citations

Bax, B.D., et al.. (2020). Conformational flexibility within the small domain of human serine racemase. Acta Crystallographica Section F Structural Biology Communications. 76(2). 65–73. 4 indexed citations

Kraft, Lucas, Louise C. Serpell, & John Atack. (2019). A Biophysical Approach to the Identification of Novel ApoE Chemical Probes. Biomolecules. 9(2). 48–48. 7 indexed citations

Ward, Simon E., Mark H Harries, Laura Aldegheri, et al.. (2019). Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile. Journal of Psychopharmacology. 34(1). 93–102. 14 indexed citations

Guillaume, Michel, Herman Borghys, L.L. de Zwart, et al.. (2016). Lipophilic nalmefene prodrugs to achieve a one-month sustained release. Journal of Controlled Release. 232. 196–202. 13 indexed citations

10.

Swanson, Devin M., Jill A. Jablonowski, Chandra Shah, et al.. (2011). The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y2 receptor. Bioorganic & Medicinal Chemistry Letters. 21(18). 5552–5556. 13 indexed citations

11.

Atack, John. (2009). Preclinical and clinical pharmacology of the GABAA receptor α5 subtype-selective inverse agonist α5IA. Pharmacology & Therapeutics. 125(1). 11–26. 95 indexed citations

12.

Atack, John. (2008). GABA_A Receptor Subtype‐Selective Efficacy: TPA023, an α2/α3 Selective Non‐sedating Anxiolytic and α5IA, an α5 Selective Cognition Enhancer. CNS Neuroscience & Therapeutics. 14(1). 25–35. 40 indexed citations

13.

Laere, Koen Van, Guy Bormans, Sandra Sanabria Bohórquez, et al.. (2008). In Vivo Characterization and Dynamic Receptor Occupancy Imaging of TPA023B, an α2/α3/α5 Subtype Selective γ-Aminobutyric Acid–A Partial Agonist. Biological Psychiatry. 64(2). 153–161. 17 indexed citations

14.

Blackaby, Wesley, John Atack, Frances A. Bromidge, et al.. (2006). Imidazo[1,2-a]pyrimidines as functionally selective GABAA ligands. Bioorganic & Medicinal Chemistry Letters. 16(5). 1175–1179. 36 indexed citations

15.

Dawson, Gerard R., Neil Collinson, & John Atack. (2005). Development of Subtype Selective GABA_AModulators. CNS Spectrums. 10(1). 21–27. 31 indexed citations

16.

Sternfeld, Francine, Robert W. Carling, Richard A. Jelley, et al.. (2004). Selective, Orally Active γ-Aminobutyric Acid _A α5 Receptor Inverse Agonists as Cognition Enhancers. Journal of Medicinal Chemistry. 47(9). 2176–2179. 92 indexed citations

17.

Reynolds, David S., Thomas W. Rosahl, Jennifer Cirone, et al.. (2003). Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms.. PubMed Central. 23(24). 8608–17. 240 indexed citations

18.

Atack, John, et al.. (2000). The 5-HT2B agonist, CP93129, inhibits GABA release from slices of rat globus pallidus and reverses akinesia following intrapallidal administration in the reserpine-treated rat. British Journal of Pharmacology. 129. 2 indexed citations

19.

Atack, John, et al.. (1989). Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.. Journal of Pharmacology and Experimental Therapeutics. 249(1). 194–202. 81 indexed citations

20.

Yu, Qian‐sheng, John Atack, Stanley I. Rapoport, & Arnold Brossi. (1988). Carbamate analogues of (−)‐physostigmine: In vitro inhibition of acetyl‐ and butyrylcholinesterase. FEBS Letters. 234(1). 127–130. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact